Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma
Status:
NOT_YET_RECRUITING
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
This study is a prospective, single arm phase II study aimed at evaluating the efficacy and safety of trilaciclib before perioperative chemotherapy in patients with osteosarcoma.
Phase:
PHASE2
Details
Lead Sponsor:
The First Affiliated Hospital of Xinxiang Medical College